155 related articles for article (PubMed ID: 3452243)
1. Immunomodulation in autoimmune diseases.
Gergely P; Láng I; Gonzalez-Cabello R; Fehér J
Tokai J Exp Clin Med; 1986; 11 Suppl():207-13. PubMed ID: 3452243
[TBL] [Abstract][Full Text] [Related]
2. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
Szegedi G
Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
[TBL] [Abstract][Full Text] [Related]
3. Treatment of autoimmune patients.
Gergely P
Acta Biomed Ateneo Parmense; 1991; 62(3-4):125-30. PubMed ID: 1840372
[No Abstract] [Full Text] [Related]
4. Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders.
Namazi MR
Int Immunopharmacol; 2004 Mar; 4(3):349-53. PubMed ID: 15037212
[TBL] [Abstract][Full Text] [Related]
5. Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants.
Biggioggero M; Borghi MO; Gerosa M; Trespidi L; Cimaz R; Meroni PI
Lupus; 2007; 16(8):651-6. PubMed ID: 17711903
[TBL] [Abstract][Full Text] [Related]
6. [Immunostimulant therapy of kidney diseases].
Karastanev I
Vutr Boles; 1982; 21(3):8-13. PubMed ID: 6180558
[No Abstract] [Full Text] [Related]
7. [Oral antibiotics with antiinflammatory/ immunomodulatory effects in the treatment of various dermatoses].
Brinkmeier T; Frosch PJ
Hautarzt; 2002 Jul; 53(7):456-65. PubMed ID: 12219268
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
Dejica D
Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
[TBL] [Abstract][Full Text] [Related]
9. [Theoretical basis of immunosuppression in autoimmune diseases].
Haustein UF
Dermatol Monatsschr; 1972 Aug; 158(8):547-71. PubMed ID: 4404036
[No Abstract] [Full Text] [Related]
10. Novel therapies in the treatment of systemic lupus erythematosus.
Dequet CR; Wallace DJ
Curr Opin Investig Drugs; 2001 Aug; 2(8):1045-53. PubMed ID: 11892912
[TBL] [Abstract][Full Text] [Related]
11. [The complement system and clinical effects of its disorders].
Siegert CE; van Es LA; Daha MR
Ned Tijdschr Geneeskd; 1996 Nov; 140(46):2268-73. PubMed ID: 8984378
[No Abstract] [Full Text] [Related]
12. [Possibility of using TFX (thymus factor X) in the treatment of systemic lupus erythematosus].
Lasisz B; Zdrojewicz Z; Dul W; Markiewicz A; Strychalski J
Pol Tyg Lek; 1989 Jul 23-30; 44(30-31):724-5. PubMed ID: 2701749
[TBL] [Abstract][Full Text] [Related]
13. Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents.
Rose B; Herder C; Löffler H; Kolb H; Martin S
J Leukoc Biol; 2004 Apr; 75(4):624-30. PubMed ID: 14704370
[TBL] [Abstract][Full Text] [Related]
14. Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
Ferraccioli GF; Tomietto P; De Santis M
Ann N Y Acad Sci; 2005 Jun; 1051():658-65. PubMed ID: 16127006
[TBL] [Abstract][Full Text] [Related]
15. [Cell-mediated immunity in autoimmune diseases (author's transl)].
Fukase M
Rinsho Byori; 1975 Jan; 23(1):40-6. PubMed ID: 1079062
[No Abstract] [Full Text] [Related]
16. [Autoimmune reactions in the area of leukocytes with special reference to drug-induced forms].
Mey U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):353-62. PubMed ID: 4139055
[No Abstract] [Full Text] [Related]
17. [Cytotoxicity of human lymphocytes induced by antibody: response in patients with systemic lupus erythematosus and effect of immunosuppressive treatment].
Manni JA; de Bracco MM; Patrucco A
Medicina (B Aires); 1974; 34(3):185-93. PubMed ID: 4547009
[No Abstract] [Full Text] [Related]
18. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases.
Nakamura T; Miyasaka N; Pope RM; Talal N; Russell IJ
Clin Exp Immunol; 1983 Apr; 52(1):67-74. PubMed ID: 6190598
[TBL] [Abstract][Full Text] [Related]
19. A critical analysis of the use of azathioprine in clinical medicine.
Ten Berge RJ; Schellekens PT
Neth J Med; 1983; 26(6):164-71. PubMed ID: 6350911
[No Abstract] [Full Text] [Related]
20. Why minocycline can cause systemic lupus - a hypothesis and suggestions for therapeutic interventions based on it.
van Steensel MA
Med Hypotheses; 2004; 63(1):31-4. PubMed ID: 15193343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
